Halozyme Therapeutics, Inc. (HALO): 8-K filed Nov 5, 2026

Form type

8-K

Filing date

Nov 5, 2026

Accession number

0001159036-26-000143

Filer

Halozyme Therapeutics, Inc. (CIK 1159036)